Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 2/20 | 0.66 |
| ▸ | ALPI | P09923 | 1/20 | 0.66 |
| ▸ | PKM | P14618 | 1/20 | 0.66 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.66 |
| ▸ | XIAP | P98170 | 1/20 | 0.66 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.66 |
| ▸ | LTA4H | P09960 | 1/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | ANPEP | P15144 | 2/20 | 0.49 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.49 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | CTSC | P53634 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL996112 | 1.00 | SLC15A1 (0.66) | SLC15A1ALPIPKMPTGS1XIAP | |
| SCHEMBL995791 | 1.00 | SLC15A1 (0.66) | SLC15A1ALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL4981923 | 0.98 | SLC15A1 (0.64) | SLC15A1ALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL1758457 | 0.98 | SLC15A1 (0.64) | SLC15A1ALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL6160157 | 0.84 | LTA4H (0.61) | LTA4HLAP3 | |
| SCHEMBL5060967 | 0.82 | ALPI (0.68) | SLC15A1ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL28138410 | 0.82 | SLC7A5 (0.88) | SLC15A1ALPIPKMPTGS1XIAP | |
| SCHEMBL12323250 | 0.82 | SLC7A5 (0.68) | SLC15A1ALPIPKMPTGS1XIAP | |
| SCHEMBL28110902 | 0.82 | ALPI (0.68) | SLC15A1ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL430395 | 0.81 | SLC7A5 (0.79) | SLC15A1ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3409765-B1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS INC (US) | 2021-08-04 | — | — | EP | disclosed |
| EP-3409765-A2 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | Codexis, Inc. (US) | 2018-12-05 | — | — | EP | disclosed |
| EP-2446025-B1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS INC (US) | 2018-08-08 | — | — | EP | disclosed |
| US-9404092-B2 | Ketoreductase-mediated stereoselective route to alpha chloroalcohols | CODEXIS, INC. (US) | 2016-08-02 | — | — | US | disclosed |
| US-20160160187-A1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2016-06-09 | — | — | US | disclosed |
| US-9296992-B2 | Ketoreductase-mediated stereoselective route to alpha chloroalcohols | CODEXIS, INC. (US) | 2016-03-29 | — | — | US | disclosed |
| EP-2955233-A1 | Proteinase K inhibitors, methods and compositions therefor | Life Technologies Corporation (US) | 2015-12-16 | — | — | EP | disclosed |
| US-20150240217-A1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2015-08-27 | — | — | US | disclosed |
| US-9114104-B2 | Proteinase K inhibitors, methods and compositions therefor | Life Technologies Corporation (US) | 2015-08-25 | — | — | US | disclosed |
| US-9114104-B2 | Proteinase K inhibitors, methods and compositions therefor | Life Technologies Corporation (US) | 2015-08-25 | — | — | US | disclosed |
| US-20130004941-A1 | PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR | Life Technologies Corporation (US) | 2013-01-03 | — | — | US | disclosed |
| US-20130004941-A1 | PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR | Life Technologies Corporation (US) | 2013-01-03 | — | — | US | disclosed |
| US-20120190086-A1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS, INC. (US) | 2012-07-26 | — | — | US | disclosed |
| US-8211637-B2 | Proteinase K inhibitors, methods and compositions therefor | Life Technologies Corporation (US) | 2012-07-03 | — | — | US | disclosed |
| US-8211637-B2 | Proteinase K inhibitors, methods and compositions therefor | Life Technologies Corporation (US) | 2012-07-03 | — | — | US | disclosed |
| EP-2446025-A2 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | Codexis, Inc. (US) | 2012-05-02 | — | — | EP | disclosed |
| WO-2011005527-A2 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS, INC. (US) | 2011-01-13 | — | — | WO | disclosed |
| WO-2010071833-A1 | PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR | Life Technologies Corporation (US) | 2010-06-24 | — | — | WO | disclosed |
| US-20100159482-A1 | PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR | Life Technologies Corporation (US) | 2010-06-24 | — | — | US | disclosed |
| US-20100159482-A1 | PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR | Life Technologies Corporation (US) | 2010-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130004941-A1 | PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR | CPSF7, CTSL, CTSK | SLC15A1 3646/4885ALPI 2591/4885PKM 680/4885 |
| US-20100159482-A1 | PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR | CPSF7, CTSL, CTSK | SLC15A1 3646/4885ALPI 2591/4885PKM 680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.